Kadenwood Raises $50M to Accelerate Leadership Position in Shaping CBD Into Mainstream Wellness Category

Kadenwood had a landmark year of growth in 2020, raising $15 million in a Series A funding round followed by the acquisition of EcoGen Biosciences, the leading global manufacturer and supplier of hemp-derived CBD materials and formulations. The deal effectively established Kadenwood as the largest supplier of vertically-integrated, hemp-derived cannabidiol (CBD) in the US, expanding the company’s ability to scale production of its quality-driven CBD products.

Kadenwood entered the consumer products marketplace in 2019 with a 100% owned seed-to-shelf capability and has grown its family of industry-leading brand portfolio to include LEVEL SELECT™ CBD, in the personal care category, Purity Preferred™ Pet CBD and Purity Organic™ CBD Teas.

“Healist has deep, strong foundations in consumer insights, and understands Sleep, Calm and Relief like no other CBD brand. We will continue our partnership with this bold CPG challenger brand by investing in Kadenwood, as we view them as the perfect home for Healist,” explains Elio Leoni Sceti, Co-Founder & Chief Crafter at The Craftory.

“With this new round of funding, we are accelerating our mission of building enduring CBD brands that people trust as being safe and effective, while cementing our position as a leading global, vertically-integrated CBD company,” said Erick Dickens, Co-Founder and CEO of Kadenwood. “This funding round solidifies our ability to execute a $20M media campaign to drive consumer awareness and support our retail partners with these industry leading brands. We’re incredibly excited by the growth ahead for Kadenwood and our family of brands as we focus on scaling and growing our business while helping shape the future of CBD and plant-based wellness.”